The FDA has received reports of adverse events and product problems associated with inferior vena cava (IVC) filters. Types of reports include device migration, filter fracture, embolization (movement of the entire filter or fracture fragments to the heart or lungs), perforation of the IVC, and difficulty removing the device. Some of these events led to adverse clinical outcomes. For more information, please see http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm396377.htm |